Inhibrx Capital Lease Obligations from 2010 to 2025
| INBX Stock | USD 14.32 0.08 0.56% |
Capital Lease Obligations | First Reported 2019-06-30 | Previous Quarter 1.8 M | Current Value 8 M | Quarterly Volatility 2.4 M |
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 10.6 M, Minority Interest of 0.0 or Tax Provision of 1.9 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0021 or PTB Ratio of 1.79. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
Inhibrx | Capital Lease Obligations |
Latest Inhibrx's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Inhibrx over the last few years. Inhibrx capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Inhibrx asset purchases. For example, Inhibrx can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Inhibrx control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Inhibrx's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Inhibrx Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 2,770,808 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 124.79 | |
| Mean Deviation | 3,117,159 | |
| Median | 0.00 | |
| Standard Deviation | 3,457,592 | |
| Sample Variance | 12T | |
| Range | 8.2M | |
| R-Value | 0.76 | |
| Mean Square Error | 5.4T | |
| R-Squared | 0.58 | |
| Significance | 0.0006 | |
| Slope | 553,847 | |
| Total Sum of Squares | 179.3T |
Inhibrx Capital Lease Obligations History
About Inhibrx Financial Statements
Inhibrx investors use historical fundamental indicators, such as Inhibrx's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 8 M | 5.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.